Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Bear Robotics Raises $81M Series B to Scale Up Mobile Robots in the Hospitality Market
Life Sciences Times
-
March 15, 2022
0
Venture Capital
Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications
Life Sciences Times
-
March 15, 2022
0
Venture Capital
The Massman Companies Acquires New England Machinery, Inc.
Life Sciences Times
-
March 15, 2022
0
Venture Capital
Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform
Life Sciences Times
-
March 14, 2022
0
Venture Capital
Texas Medical Center Doubles the Size of the TMC Venture Fund
Life Sciences Times
-
March 14, 2022
0
Venture Capital
RefleXion Raises $80 Million to Broaden Cancer Treatment Options
Life Sciences Times
-
March 10, 2022
0
Venture Capital
Rightsline Acquires REAL Software Systems, Expanding from Hollywood into a Global IP Commerce Powerhouse
Life Sciences Times
-
March 10, 2022
0
Venture Capital
Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
Life Sciences Times
-
March 9, 2022
0
Venture Capital
UroGen Secures $100 Million Non-Dilutive Term Loan Financing with Pharmakon Advisors Allowing Funding to Cash Flow Breakeven
Life Sciences Times
-
March 8, 2022
0
Venture Capital
DNAnexus Secures $200 Million Funding Led by Blackstone Growth to Advance its Biomedical Data-Driven Technology Platform for Precision Medicine
Life Sciences Times
-
March 8, 2022
0
Venture Capital
Minnesota Rubber and Plastics Acquires Primasil Silicones Ltd.
Life Sciences Times
-
March 7, 2022
0
Venture Capital
Microbiotica Raises ÂŁ50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics
Life Sciences Times
-
March 7, 2022
0
1
...
82
83
84
...
115
Page 83 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026